Hungary

我们是谁

• 1 月 17, 2024

  ZN-c3 in Adult Participants With BRAF mutant Metastatic Colorectal Cancer

• 1 月 10, 2024

  评估INCB099280对免疫检查点抑制剂无效的特定实体瘤患者的作用的研究

• 1 月 9, 2024

  Evaluation of Co-formulated Pembrolizumab/Quavonlimab (MK-1308A) Versus Other Treatments in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Cancer (CRC) (MK-1308A-008)

• 11 月 15, 2022

  Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer (STELLAR-303)

• 4 月 5, 2022

  Repotrectinib（TPX-0005）对携带 ALK、ROS1 或 NTRK1-3 基因重排的晚期实体瘤患者的研究

• 4 月 5, 2022

  A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100)